Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.
NCT03833141
·
clinicaltrials.gov ↗
COMPLETED
Status
170
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Eosinophilic Asthma
Interventions
OTHER:
Survey Administration
Sponsor
AstraZeneca